Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature

OBJECTIVE: To assess whether the polymyalgia rheumatica (PMR)-like syndrome reported as an immune related adverse event (irAE) from checkpoint inhibitor therapy is consistent with the 2012 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) provisional criteria for PMR....

Descripción completa

Detalles Bibliográficos
Autores principales: Calabrese, Cassandra, Cappelli, Laura C, Kostine, Marie, Kirchner, Elizabeth, Braaten, Tawnie, Calabrese, Leonard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Miscellaneous
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525600/
https://www.ncbi.nlm.nih.gov/pubmed/31168414
http://dx.doi.org/10.1136/rmdopen-2019-000906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525600/
https://www.ncbi.nlm.nih.gov/pubmed/31168414
http://dx.doi.org/10.1136/rmdopen-2019-000906

Ejemplares similares